-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RCPhM5Zr7Mu6kyAEAOOF2m1U3nRVVXbGtoTDwOFxeGEVi6afbrM6hX67iUq7j+Ph
 HOf5NwCCuSRQAuEui95TAQ==

<SEC-DOCUMENT>0001179110-07-016261.txt : 20070808
<SEC-HEADER>0001179110-07-016261.hdr.sgml : 20070808
<ACCEPTANCE-DATETIME>20070808123035
ACCESSION NUMBER:		0001179110-07-016261
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070801
FILED AS OF DATE:		20070808
DATE AS OF CHANGE:		20070808

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRUKER BIOSCIENCES CORP
		CENTRAL INDEX KEY:			0001109354
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043110160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

	MAIL ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER DALTONICS INC
		DATE OF NAME CHANGE:	20000315

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LAUKIEN FRANK H
		CENTRAL INDEX KEY:			0001133649

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30833
		FILM NUMBER:		071034493

	MAIL ADDRESS:	
		STREET 1:		C/O BRUKER DALTONICS
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 4/A -
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2007-08-01</periodOfReport>

    <dateOfOriginalSubmission>2007-08-03</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001109354</issuerCik>
        <issuerName>BRUKER BIOSCIENCES CORP</issuerName>
        <issuerTradingSymbol>BRKR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001133649</rptOwnerCik>
            <rptOwnerName>LAUKIEN FRANK H</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O BRUKER BIOSCIENCES CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>40 MANNING PARK</rptOwnerStreet2>
            <rptOwnerCity>BILLERICA</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>01821</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>CEO, President</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable></nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>8.75</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2007-08-01</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>100000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2008-08-01</value>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2012-08-01</value>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>100000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1000000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The original Form 4 is amended to correct the exercise price, vesting provisions and expiration date of the option grant.  The option vests in four equal annual installments beginning on August 1, 2008.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Frank H. Laukien</signatureName>
        <signatureDate>2007-08-08</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----